Shares of DARA Biosciences Inc (NASDAQ:DARA) fell 3% during mid-day trading on Monday . The company traded as low as $0.32 and last traded at $0.32. 22,737 shares were traded during trading, a decline of 81% from the average session volume of 118,843 shares. The stock had previously closed at $0.33.
The firm has a 50-day moving average price of $0.30.
About DARA Biosciences (NASDAQ:DARA)
DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company’s primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth).
Recommended Story: Quiet Period Expirations
Receive News & Ratings for DARA Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DARA Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.